Literature DB >> 2935072

Neuropathy associated with experimental Chagas' disease.

G Said, M Joskowicz, A A Barreira, H Eisen.   

Abstract

Mice were acutely and chronically infected with Trypanosoma cruzi and then examined histologically for the presence of lesions in the peripheral nervous system. In acutely infected animals, small lymphocytic and macrophagic infiltrates were found in the nerves in association with intracellular parasites. Little or no nerve damage was present at this stage. In chronically infected animals, large perivascular granulomatous infiltrates were found in association with multifocal, predominantly demyelinative lesions of neighboring nerve fibers. Similar inflammatory infiltrates were present in muscles and were frequently associated with vasculitis and destruction of muscle fibers. Our pathological findings and the negative results produced by intraneural injections of sera from chronically infected animals and the positive results following injections of small numbers of live trypanosomes suggest that the demyelination is not due to circulating serum factors such as antibodies cross-reacting with peripheral myelin. Delayed-type hypersensitivity may be induced by the presence of the parasites, a notion supported by the development of granulomas in naive mice injected intravenously with helper T cells from chronically infected animals.

Entities:  

Mesh:

Year:  1985        PMID: 2935072     DOI: 10.1002/ana.410180609

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase.

Authors:  F S Buckner; A J Wilson; W C Van Voorhis
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells.

Authors:  M V Chuenkova; M A Pereira
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

4.  Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease.

Authors:  R L Tarleton; J Sun; L Zhang; M Postan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice.

Authors:  Ester Roffê; Ana Paula M P Marino; Joseph Weaver; Wuzhou Wan; Fernanda F de Araújo; Victoria Hoffman; Helton C Santiago; Philip M Murphy
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

6.  Circulating antibodies against nicotinic acetylcholine receptors in chagasic patients.

Authors:  J C Goin; G Venera; M Biscoglio de Jiménez Bonino; L Sterin-Borda
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

Review 7.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

Review 8.  Autonomic neuropathy and immunological abnormalities in Chagas' disease.

Authors:  A Fernandez; M Hontebeyrie; G Said
Journal:  Clin Auton Res       Date:  1992-12       Impact factor: 4.435

9.  Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease.

Authors:  Claudio R F Marinho; Daniella Z Bucci; Maria Lúcia Z Dagli; Karina R B Bastos; Marcos G Grisotto; Luiz R Sardinha; Cristiane R G M Baptista; Carlos Penha Gonçalves; Maria Regina D'Império Lima; José M Alvarez
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Fl-160. A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue.

Authors:  W C Van Voorhis; H Eisen
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.